Literature DB >> 16172741

Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix.

M Paez-Pereda1, F Kuchenbauer, E Arzt, G K Stalla.   

Abstract

The extracellular matrix is a three-dimensional network of proteins, glycosaminoglycans and other macromolecules. It has a structural support function as well as a role in cell adhesion, migration, proliferation, differentiation, and survival. The extracellular matrix conveys signals through membrane receptors called integrins and plays an important role in pituitary physiology and tumorigenesis. There is a differential expression of extracellular matrix components and integrins during the pituitary development in the embryo and during tumorigenesis in the adult. Different extracellular matrix components regulate adrenocorticotropin at the level of the proopiomelanocortin gene transcription. The extracellular matrix also controls the proliferation of adrenocorticotropin-secreting tumor cells. On the other hand, laminin regulates the production of prolactin. Laminin has a dynamic pattern of expression during prolactinoma development with lower levels in the early pituitary hyperplasia and a strong reduction in fully grown prolactinomas. Therefore, the expression of extracellular matrix components plays a role in pituitary tumorigenesis. On the other hand, the remodeling of the extracellular matrix affects pituitary cell proliferation. Matrix metalloproteinase activity is very high in all types of human pituitary adenomas. Matrix metalloproteinase secreted by pituitary cells can release growth factors from the extracellular matrix that, in turn, control pituitary cell proliferation and hormone secretion. In summary, the differential expression of extracellular matrix components, integrins and matrix metalloproteinase contributes to the control of pituitary hormone production and cell proliferation during tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172741     DOI: 10.1590/s0100-879x2005001000005

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  21 in total

Review 1.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

Review 2.  Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease.

Authors:  Sumit Ghosh; Scott A Hoselton; Glenn P Dorsam; Jane M Schuh
Journal:  Immunobiology       Date:  2014-12-31       Impact factor: 3.144

Review 3.  The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas.

Authors:  M Victoria Recouvreux; M Andrea Camilletti; Daniel B Rifkin; Graciela Díaz-Torga
Journal:  J Endocrinol       Date:  2015-12-23       Impact factor: 4.286

4.  Paclitaxel induces apoptosis and reduces proliferation by targeting epidermal growth factor receptor signaling pathway in oral cavity squamous cell carcinoma.

Authors:  Jing Hu; N A Zhang; Ronglin Wang; Fei Huang; Guang Li
Journal:  Oncol Lett       Date:  2015-07-16       Impact factor: 2.967

5.  Analysis of differential gene expression by bead-based fiber-optic array in growth-hormone-secreting pituitary adenomas.

Authors:  Zhiquan Jiang; Songbo Gui; Yazhuo Zhang
Journal:  Exp Ther Med       Date:  2010-07-21       Impact factor: 2.447

6.  Tissue inhibitors of metalloproteinase-expressing cells in human anterior pituitary and pituitary adenoma.

Authors:  Alimuddin Tofrizal; Ken Fujiwara; Morio Azuma; Motoshi Kikuchi; Depicha Jindatip; Takashi Yashiro; Shozo Yamada
Journal:  Med Mol Morphol       Date:  2017-03-28       Impact factor: 2.309

7.  The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomas.

Authors:  Ozgur Mete; Caroline Hayhurst; Hussein Alahmadi; Eric Monsalves; Hasan Gucer; Fred Gentili; Shereen Ezzat; Sylvia L Asa; Gelareh Zadeh
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

8.  Alterations of collagen-producing cells in human pituitary adenomas.

Authors:  Alimuddin Tofrizal; Ken Fujiwara; Takashi Yashiro; Shozo Yamada
Journal:  Med Mol Morphol       Date:  2016-04-28       Impact factor: 2.309

9.  Analysis of differential gene expression in plurihormonal pituitary adenomas using bead-based fiber-optic arrays.

Authors:  Zhiquan Jiang; Songbai Gui; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2012-05-16       Impact factor: 4.130

10.  Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1.

Authors:  M Jian; Q Du; D Zhu; Z Mao; X Wang; Y Feng; Z Xiao; H Wang; Y Zhu
Journal:  J Endocrinol Invest       Date:  2018-10-28       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.